Rinnakkaislääkkeet
Rinnakkaislääkkeet, also known as parallel medicines or parallel imported medicines, refer to medicines that are authorized in one European Economic Area (EEA) country and then imported from another EEA country where they are also authorized and marketed. The purpose of parallel trade is to leverage price differences between different member states within the EU. A company may import a medicine that is already authorized in Finland from another EU country where it is sold at a lower price.
The medicines are identical in terms of active substance, strength, dosage form, and therapeutic effect to the
The availability of rinnakkaislääkkeet can contribute to increased competition in the pharmaceutical market, potentially leading to